Pharma Firms Want Protection From FDA Actions When Listing On ClinicalTrials.Gov

Pharmaceutical manufacturers are seeking assurances from FDA that information about clinical studies posted on clinicaltrials.gov will not expose them to charges of promoting products for unapproved uses

More from Archive

More from Pink Sheet